UBS Initiates Coverage On Oscar Health with Neutral Rating, Announces Price Target of $23
Portfolio Pulse from Benzinga Newsdesk
UBS has initiated coverage on Oscar Health with a Neutral rating and set a price target of $23.
October 07, 2024 | 3:28 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
UBS has initiated coverage on Oscar Health with a Neutral rating and set a price target of $23, indicating a balanced view on the stock's potential.
The Neutral rating suggests that UBS sees neither strong upside nor downside potential in the short term for Oscar Health. The price target of $23 provides a benchmark for investors, but the neutral stance indicates a wait-and-see approach.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100